Clinical Trials
2 trialsNCT02162758 2017-05-11
Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation
Takeda
Phase 2 Terminated
NCT01093755 2016-03-17
Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?
Mayo Clinic
Phase 4 Completed